MarketInOut Stock Screener Log In | Sign Up

AbbVie Inc

VIE • Healthcare • Drug Manufacturers - General • Quote as of 10/27/2026 17:32
AbbVie Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeVIE
Market Capitalization454,326 mln
Float1,765 mln
Earnings Date10/30/2026

EPS

3.03
Stretched

P / E

84.62
Speculative

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.86
Likely reliable

Relative Strength

73 / 100
Outperforming

Pre-Tax Margin

14%
Moderate margin

Business Description

AbbVie is a global medicine company that researches, develops, and sells treatments across a wide range of health conditions, including cancer, autoimmune disorders, neurological conditions, eye diseases, and digestive health. Its portfolio includes well-known products such as Skyrizi, Rinvoq, Imbruvica, Botox, and Juvederm, among many others. Founded in 2012 and based in North Chicago, Illinois, AbbVie operates worldwide and also offers aesthetic and skincare solutions alongside its pharmaceutical business.

Key Fundamentals

EPS3.03
P/E84.62
ROIC14.21
ROA4.66
Interest Cover7.13
EBITDA, mln16,898
EV / EBITDA26.79
EV / EBIT44.76
Revenue, mln55,213
EV / Revenue8.19

Quote Details

Last 257.20
Change 2.5 (0.98%)
Open 261.20
Volume 3
Turnover 771.6
Average Volume 0.1429

Financial Ratios

Pre-Tax Profit Margin14
Current Ratio0.81
Price / Free Cash Flow25.47
Price / Sales7.20
PEG Ratio0.58

Financial Strength

Altman Z-Score2.48
Piotroski F-Score 8 / 9
Beneish M-Score-2.86
Price to Intrinsic Value2.56
Shiller PE Ratio54.31

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.78% 60 / 100   
1 Month 11.48% 84 / 100   
2 Months 13.84% 81 / 100   
6 Months 53.5% 95 / 100   
1 Year 32.15% 75 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog